Morgan Cheatham is a Vice President with Bessemer Venture Partners where he leads healthcare and life sciences investments from seed to growth stages. He focuses across the value chain spanning software, therapeutics, services, and diagnostics and specializes in applications of computation in biomedicine.

Select investments in his portfolio include Abridge, Hinge Health, Headspace Health, Subtle Medical, Turquoise Health, Productboard, Plenful, Groups, Ansible Health, and FOLX Health. He was awarded Forbes 30U30 for Venture Capital and the National Venture Capital Association Rising Star Award in 2023.

Morgan is pursuing medical training at Brown University with a research focus in bioinformatics. His work investigates questions pertaining to clinical validation, phenotyping, and therapeutic response prediction via large multi-modal model approaches in collaboration with the Shah Lab at Stanford and the Zitnik Lab at Harvard. Morgan is also a member of the New England Journal of Medicine Artificial Intelligence Editorial Team.

Isaac “Zak” Kohane, MD, PhD, is the inaugural chair of Harvard Medical School’s Department of Biomedical Informatics, whose mission is to develop the methods, tools, and infrastructure required for a new generation of scientists and care providers to move biomedicine rapidly forward by taking advantage of the insight and precision offered by big data. Kohane develops and applies computational techniques to address disease at multiple scales, from whole health care systems to the functional genomics of neurodevelopment.

He also has worked on AI applications in medicine since the 1990’s, including automated ventilator control, pediatric growth monitoring, detection of domestic abuse, diagnosing autism from multimodal data and most recently assisting clinicians using whole genome sequence and clinical histories to diagnose rare or unknown disease patients.

His most urgent question is how to enable doctors to be most effective and enjoy their profession when they enter into a substantial symbiosis with machine intelligence. He is a member of the National Academy of Medicine, the American Society for Clinical Investigation and the American College of Medical Informatics.